Verma Abhyuday, Jayaraman Muthukrishnan, Kumar Hari K V S, Modi Kirtikumar D
Department of Endocrinology, Medwin Hospitals, Nampally, Hyderabad, India.
Saudi Med J. 2008 Aug;29(8):1135-8.
To establish relationship between obesity and hypothyroidism and to analyze the frequency the frequency of primary hypothyroidism in obese patients and frequency of obesity in primary hypothyroidism patients.
We conducted this retrospective, observational study in the Department of Endocrinology and Obesity Clinic, Medwin Hospital, Hyderabad, India in Mar 2008. In the last 18 months (between September 2006 to February 2008), data on 625 consecutive primary hypothyroidism patients (Group I) and 450 patients from obesity clinic (Group II) were analyzed. Frequency difference between the 2 groups was assessed by Chi-square test.
In Group I, 278/625 (44%) had body mass index (BMI) >25 kg/m2. Obesity was higher (46% versus 34%) in overt hypothyroidism than in subclinical hypothyroidism (p=0.21). More patients were overweight in overt hypothyroidism group than in subclinical hypothyroidism group (p=0.02). In obesity patients, overt hypothyroidism was present in 33% and subclinical hypothyroidism in 11% patients.
Overall thyroid dysfunction was found more in obese individuals with varying degree of significance. Detailed studies are required to assess the cause and effect relation between obesity and hypothyroidism.
建立肥胖与甲状腺功能减退之间的关系,并分析肥胖患者中原发性甲状腺功能减退的发生率以及原发性甲状腺功能减退患者中肥胖的发生率。
2008年3月,我们在印度海得拉巴市梅德温医院内分泌科和肥胖诊所进行了这项回顾性观察研究。分析了过去18个月(2006年9月至2008年2月)期间625例连续的原发性甲状腺功能减退患者(第一组)和450例肥胖诊所患者(第二组)的数据。通过卡方检验评估两组之间的频率差异。
在第一组中,278/625(44%)的体重指数(BMI)>25 kg/m²。显性甲状腺功能减退患者的肥胖率(46%对34%)高于亚临床甲状腺功能减退患者(p = 0.21)。显性甲状腺功能减退组超重的患者比亚临床甲状腺功能减退组更多(p = 0.02)。在肥胖患者中,33%存在显性甲状腺功能减退,11%存在亚临床甲状腺功能减退。
在肥胖个体中发现总体甲状腺功能障碍更为常见,且具有不同程度的显著性。需要进行详细研究以评估肥胖与甲状腺功能减退之间的因果关系。